Date: 9 October 2026 (Letter date), 12 October 2026 (Receipt date)
KMP / Board / Auditor Changes
- Mr. Umang Vohra (DIN: 02296740) has received Central Government approval for his appointment as Chairman and Group CEO of Cohance Lifesciences Limited.
- The approval was granted by the Ministry of Corporate Affairs (Central Government) vide its letter dated 8 October 2026, which was received by the Company on 12 October 2026.
- This appointment is in continuation of the company's previous intimations dated 27 April 2026 and 26 June 2026 regarding the same appointment.
- The effective date of appointment is not explicitly stated in the document.
Other Operational / Legal / Strategic Disclosures
- The company has complied with regulatory requirements by intimating both BSE Limited and National Stock Exchange of India Limited about this development.
- The communication was signed by Sisir K. Mishra (Sisira Kumar Mishra), Company Secretary & Compliance Officer, on 12 October 2026 at 19:47:22 IST.